Literature DB >> 9130297

Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat.

T Puumala1, P Riekkinen, J Sirviö.   

Abstract

This study investigated the role of alpha-1 adrenergic receptors in the modulation of attention and behavioral activity by assessing the effects of alpha-1 adrenergic receptor stimulation or blockade on the performance of rats in tasks involving vigilance (sustained attention) and selective attention [five-choice serial reaction time (5-CSRT)]. Pretesting subcutaneous administration of St-587 (a putative alpha-1 agonist) at 100 micrograms/kg, but not at 300 or 1000 micrograms/kg, significantly improved the choice accuracy of rats in the 5-CSRT task (monitoring of visual stimuli), whereas prazosin (a prototype alpha-1 antagonist) at 300 micrograms/kg administered subcutaneously slightly impaired choice accuracy of the rats in this task. Prazosin at 100 micrograms/kg blocked the ability of St-587 at 100 micrograms/kg to improve choice accuracy. Furthermore, St-587 at 100 micrograms/kg significantly increased the number of trials completed and reduced the probability of premature responses, whereas prazosin at 300 micrograms/kg decreased the number of trials completed and the latency of animals to make correct responses in the task. Prazosin at 100 micrograms/kg blocked the effect of St-587 at 100 micrograms/kg in increasing the number of trials completed. However, prazosin at 100 micrograms/kg did not abolish the effect of St-587 in reducing the probability of premature responses. Because the effect of St-587 at 100 micrograms/kg in improving choice accuracy is rather modest, it is possible that when the 100- and 300-microgram/kg doses of St-587 were administered in a counterbalanced order, this effect could have been overlooked due to day-to-day variation. Thus, the present results suggest that stimulation of alpha-1 adrenergic receptors can facilitate vigilance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130297     DOI: 10.1016/s0091-3057(96)00408-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

Review 1.  CNTRICS final animal model task selection: control of attention.

Authors:  C Lustig; R Kozak; M Sarter; J W Young; T W Robbins
Journal:  Neurosci Biobehav Rev       Date:  2012-06-06       Impact factor: 8.989

2.  Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex.

Authors:  Dibyadeep Datta; Sheng-Tao Yang; Veronica C Galvin; John Solder; Fei Luo; Yury M Morozov; Jon Arellano; Alvaro Duque; Pasko Rakic; Amy F T Arnsten; Min Wang
Journal:  J Neurosci       Date:  2019-02-12       Impact factor: 6.167

3.  Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.

Authors:  Courtney A Marshall; Zachary D Brodnik; Ole V Mortensen; Maarten E A Reith; Jed S Shumsky; Barry D Waterhouse; Rodrigo A España; Sandhya Kortagere
Journal:  Neuropharmacology       Date:  2019-01-08       Impact factor: 5.250

4.  On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists.

Authors:  Tommy Pattij; Dustin Schetters; Anton N M Schoffelmeer; Marcel M van Gaalen
Journal:  Psychopharmacology (Berl)       Date:  2011-07-19       Impact factor: 4.530

Review 5.  Pharmacological enhancement of memory and executive functioning in laboratory animals.

Authors:  Stan B Floresco; James D Jentsch
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

6.  Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists.

Authors:  Britta Hahn; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2004-07-14       Impact factor: 4.530

Review 7.  Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Authors:  Y Chudasama; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

Review 8.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

Review 9.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

10.  Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task.

Authors:  Yia-Ping Liu; Yu-Lung Lin; Chia-Hsin Chuang; Yu-Cheng Kao; Shang-Tang Chang; Che-Se Tung
Journal:  J Biomed Sci       Date:  2009-08-14       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.